Your browser doesn't support javascript.
loading
3D Visualization System-Assisted Vitrectomy for Rhegmatogenous Retinal Detachment: Leave Out the Perfluorocarbon Liquid.
Guan, Lina; Chen, Jiayu; Tang, Yu; Lu, Zhaolin; Zhang, Zhengpei; Ji, Sujuan; Li, Meili; Liu, Yalu; Li, Suyan; Liu, Haiyang.
Afiliación
  • Guan L; The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China.
  • Chen J; Department of Ophthalmology, Xuzhou First People's Hospital, Xuzhou, China.
  • Tang Y; Eye Disease Prevention and Treatment Institute of Xuzhou, Xuzhou, China.
  • Lu Z; The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhang Z; Department of Ophthalmology, Xuzhou First People's Hospital, Xuzhou, China.
  • Ji S; Eye Disease Prevention and Treatment Institute of Xuzhou, Xuzhou, China.
  • Li M; The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China.
  • Liu Y; Department of Ophthalmology, Xuzhou First People's Hospital, Xuzhou, China.
  • Li S; Eye Disease Prevention and Treatment Institute of Xuzhou, Xuzhou, China.
  • Liu H; China University of Mining and Technology, Xuzhou, China.
Ophthalmol Ther ; 12(3): 1611-1619, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36869993
ABSTRACT

INTRODUCTION:

Pars plana vitrectomy (PPV) is a primary strategy to restore vision for patients who have rhegmatogenous retinal detachment (RRD). Perfluorocarbon liquid (PFCL) is frequently used during PPV surgery. However, the unintended intraocular retention of PFCL may cause retina toxicity and thus lead to possible postoperative complications. In this paper, the experiences and surgical outcomes of a NGENUITY 3D Visualization System-assisted PPV are shown to evaluate the possibility of excluding the application of PFCL.

METHODS:

A consecutive series of 60 cases with RRD were presented, all of whom had undergone 23-gauge PPV with the assistance of a three-dimensional (3D) visualization system. Among them, 30 cases used PFCL to assist the drainage of subretinal fluid (SRF), while the other 30 cases did not. Parameters including retinal reattachment rate (RRR), best-corrected visual acuity (BCVA), operation time, and SRF residual were compared between the two groups.

RESULTS:

Baseline data showed no statistical significance between the two groups. At the last postoperative follow-up, the RRR of all the 60 cases reached 100% and best-corrected visual acuity (BCVA) gained significant improvement. The BCVA (logMAR) increased from 1.293 ± 0.881 to 0.479 ± 0.316 in the PFCL-excluded group, exhibiting better results than the PFCL included group, whose final BCVA was 0.650 ± 0.371. More importantly, excluding PFCL greatly reduced the operation time (decrease of 20%), therefore, avoiding possible complications caused by both the use of PFCL and the operation process.

CONCLUSION:

With the assistance of the 3D visualization system, it is feasible to treat RRD and perform PPV without using PFCL. The 3D visualization system is highly recommendable, as not only can it achieve the same surgical effect without the assistance of PFCL, but also simplify the operation procedure, shorten the operation time, save costs, and avoid complications related to PFCL.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ophthalmol Ther Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ophthalmol Ther Año: 2023 Tipo del documento: Article País de afiliación: China